683 Capital Management LLC Acquires New Shares in Alpha Teknova, Inc. (NASDAQ:TKNO)

683 Capital Management LLC bought a new position in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 89,076 shares of the company's stock, valued at approximately $744,000. 683 Capital Management LLC owned approximately 0.17% of Alpha Teknova at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in shares of Alpha Teknova by 622.5% in the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock valued at $37,000 after purchasing an additional 3,791 shares during the period. Mount Lucas Management LP acquired a new position in shares of Alpha Teknova in the fourth quarter valued at approximately $75,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Alpha Teknova during the fourth quarter worth $94,000. NewEdge Advisors LLC raised its holdings in shares of Alpha Teknova by 14.3% during the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after acquiring an additional 1,953 shares during the period. Finally, Barclays PLC acquired a new position in Alpha Teknova in the 4th quarter worth $132,000. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Stock Performance

Shares of TKNO stock opened at $6.61 on Friday. The company has a fifty day moving average price of $5.78 and a two-hundred day moving average price of $7.11. Alpha Teknova, Inc. has a one year low of $1.16 and a one year high of $10.37. The stock has a market cap of $353.22 million, a P/E ratio of -8.93 and a beta of 0.54. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.11) earnings per share for the quarter. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.27 million for the quarter, compared to analyst estimates of $9.10 million. As a group, equities analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Analyst Ratings Changes

Separately, Craig Hallum initiated coverage on Alpha Teknova in a report on Monday, February 10th. They set a "buy" rating and a $12.00 price objective for the company.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.